Ball, T M
Goldstein-Piekarski, A N
Gatt, J M
Williams, L M
Article History
Received: 3 March 2017
Revised: 26 June 2017
Accepted: 6 July 2017
First Online: 17 October 2017
Competing interests
: LMW is currently receiving fees as a scientific advisor for Psyberguide and BlackThorn Therapeutics, and previously within the past 3 years received fees as a consultant for Humana. JMG has previously received consultancy fees from Brain Resource unrelated to this study and is a stockholder in MAP. TMB has received fees as a content contributor for Psyberguide. The remaining author declares no conflict of interest.